When cancer patients were divided into two subgroups according to median ABCG2 expression, no significant difference in overall survival probability was found between the high- and low-expression groups for colon (p = 0.51) or rectal adenocarcinomas (p = 0.24). Here, ABCG2 is linked to cancer.